Cargando…
Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study
Therapeutic options for psoriasis vulgaris have changed during recent decades with the introduction of biologics. Few nationwide studies are available on psoriasis treatment patterns, and those from Finland predate the use of biologics. The aim of this retrospective, population-based registry study...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012470/ https://www.ncbi.nlm.nih.gov/pubmed/36892511 http://dx.doi.org/10.2340/actadv.v103.3491 |
_version_ | 1784906611823738880 |
---|---|
author | VESIKANSA, Aino MEHTÄLÄ, Juha PESU, Marko AALTONEN, Jaakko KONTTINEN, Riikka TASANEN, Kaisa HUILAJA, Laura |
author_facet | VESIKANSA, Aino MEHTÄLÄ, Juha PESU, Marko AALTONEN, Jaakko KONTTINEN, Riikka TASANEN, Kaisa HUILAJA, Laura |
author_sort | VESIKANSA, Aino |
collection | PubMed |
description | Therapeutic options for psoriasis vulgaris have changed during recent decades with the introduction of biologics. Few nationwide studies are available on psoriasis treatment patterns, and those from Finland predate the use of biologics. The aim of this retrospective, population-based registry study was to identify patients with psoriasis vulgaris and their treatment patterns in the secondary care setting in Finland. The study cohort included 41,456 adults with a diagnosis of psoriasis vulgaris in the public secondary healthcare setting from 2012 through 2018. Data on comorbidities, pharmacotherapy, and phototherapy were collected from nationwide healthcare and drug registries. Patients in the cohort had a wide range of comorbidities, with 14.9% having psoriatic arthritis. Treatment was based largely on topical and conventional systemic medications. Conventional medications were used by 28.9% of patients, and methotrexate was the most common option (20.9%). Biologics were used by 7.3% of patients, mostly as second- and third-line treatment. The use of conventional systemic medications, topical treatments, and phototherapy decreased after the initiation of biologics. This study of psoriasis vulgaris in Finland provides a framework for the development of future care practices. SIGNIFICANCE This population-based study identified adult patients with psoriasis vulgaris (psoriasis) and their treatment patterns in the secondary care setting in Finland. The results indicate that patients with psoriasis had a wide range of comorbidities, with 15% having psoriatic arthritis. Treatment was based largely on topical treatments. Conventional systemic (oral) medications were used by approximately 30% and biological treatments by 7% of patients. The results provide important information on psoriasis patients and their current treatment patterns and form a framework for the development of future care practices for psoriasis in Finland. |
format | Online Article Text |
id | pubmed-10012470 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica |
record_format | MEDLINE/PubMed |
spelling | pubmed-100124702023-03-15 Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study VESIKANSA, Aino MEHTÄLÄ, Juha PESU, Marko AALTONEN, Jaakko KONTTINEN, Riikka TASANEN, Kaisa HUILAJA, Laura Acta Derm Venereol Original Report Therapeutic options for psoriasis vulgaris have changed during recent decades with the introduction of biologics. Few nationwide studies are available on psoriasis treatment patterns, and those from Finland predate the use of biologics. The aim of this retrospective, population-based registry study was to identify patients with psoriasis vulgaris and their treatment patterns in the secondary care setting in Finland. The study cohort included 41,456 adults with a diagnosis of psoriasis vulgaris in the public secondary healthcare setting from 2012 through 2018. Data on comorbidities, pharmacotherapy, and phototherapy were collected from nationwide healthcare and drug registries. Patients in the cohort had a wide range of comorbidities, with 14.9% having psoriatic arthritis. Treatment was based largely on topical and conventional systemic medications. Conventional medications were used by 28.9% of patients, and methotrexate was the most common option (20.9%). Biologics were used by 7.3% of patients, mostly as second- and third-line treatment. The use of conventional systemic medications, topical treatments, and phototherapy decreased after the initiation of biologics. This study of psoriasis vulgaris in Finland provides a framework for the development of future care practices. SIGNIFICANCE This population-based study identified adult patients with psoriasis vulgaris (psoriasis) and their treatment patterns in the secondary care setting in Finland. The results indicate that patients with psoriasis had a wide range of comorbidities, with 15% having psoriatic arthritis. Treatment was based largely on topical treatments. Conventional systemic (oral) medications were used by approximately 30% and biological treatments by 7% of patients. The results provide important information on psoriasis patients and their current treatment patterns and form a framework for the development of future care practices for psoriasis in Finland. Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023-03-09 /pmc/articles/PMC10012470/ /pubmed/36892511 http://dx.doi.org/10.2340/actadv.v103.3491 Text en © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | Original Report VESIKANSA, Aino MEHTÄLÄ, Juha PESU, Marko AALTONEN, Jaakko KONTTINEN, Riikka TASANEN, Kaisa HUILAJA, Laura Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title | Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title_full | Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title_fullStr | Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title_full_unstemmed | Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title_short | Comorbidities and Medication Use in Finnish Patients with Psoriasis: A Population-Based Registry Study |
title_sort | comorbidities and medication use in finnish patients with psoriasis: a population-based registry study |
topic | Original Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10012470/ https://www.ncbi.nlm.nih.gov/pubmed/36892511 http://dx.doi.org/10.2340/actadv.v103.3491 |
work_keys_str_mv | AT vesikansaaino comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT mehtalajuha comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT pesumarko comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT aaltonenjaakko comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT konttinenriikka comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT tasanenkaisa comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy AT huilajalaura comorbiditiesandmedicationuseinfinnishpatientswithpsoriasisapopulationbasedregistrystudy |